Biogen, Inc. (BIIB)
Biogen Market Cap : 27.12B for March 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Eli Lilly & Co. | 933.45B |
| AbbVie, Inc. | 406.87B |
| Merck & Co., Inc. | 286.28B |
| Alnylam Pharmaceuticals, Inc. | 42.53B |
| Pfizer Inc. | 153.47B |
Market Cap Related Metrics
| PE Ratio | 20.99 |
| PS Ratio | 2.845 |
| Price to Book Value | 1.486 |
| Price to Free Cash Flow | 13.77 |
| Price | 184.81 |
| Earnings Yield | 4.76% |
| Operating PE Ratio | 11.21 |
| Normalized PE Ratio | 15.85 |